We’re looking forward to joining the biopharma community at the Bio International Convention in June 2024. Members of the Mogrify team, including CEO, Darrin M Disley, will be on hand to navigate you through the latest advancements across the MOGRIFY® direct reprogramming platform and the anticipated development milestones in each of our therapeutic programs over the next 24 months.
Connect via BIO Partnering, contact us via email to arrange a catch-up.